Cor­texyme switch­es di­rec­tion, an­nounces lay­offs af­ter FDA slaps hold on dark horse Alzheimer’s can­di­date

Cor­texyme’s ef­forts to de­vel­op an out­side-the-box treat­ment for Alzheimer’s took a sig­nif­i­cant hit Tues­day.

The biotech an­nounced the FDA has put a full clin­i­cal hold …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER